Hepatitis C in patients co-infected with human immunodeficiency virus. A review and experience of a Brazilian ambulatory

Authors

  • Maria Cássia Jacintho Mendes-Corrêa University of São Paulo; Medical School; Laboratory of Medical Investigation in Hepatitis LIM 47
  • Antonio Alci Barone University of São Paulo; Medical School; Laboratory of Medical Investigation in Hepatitis LIM 47

Keywords:

HIV, Hepatitis C, Review, Brazil

Abstract

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) share the same transmission mechanisms. The prevalence of HCV in the HIV-infected population varies from region to region, throughout the world, depending on different exposure factors to both viruses. Co-infection with HIV accelerates the progression of the disease caused by HCV, appears to worsen the progression of the HIV infection and increases HCV transmission. Therefore, clinical management and treatment of HCV is a priority in medical facilities that receive HIV-infected patients. Clinical management of these patients involves specific diagnostic procedures and appropriately trained medical staff. The indication of treatment should meet specific clinical and laboratory criteria. There are a number of drugs currently available to treat hepatitis C in co-infected patients.

Downloads

Download data is not yet available.

Downloads

Published

2005-04-01

Issue

Section

Reviews

How to Cite

Mendes-Corrêa, M. C. J., & Barone, A. A. (2005). Hepatitis C in patients co-infected with human immunodeficiency virus. A review and experience of a Brazilian ambulatory . Revista Do Instituto De Medicina Tropical De São Paulo, 47(2), 59-64. https://revistas.usp.br/rimtsp/article/view/30887